1. ScholarBank@NUS

Wee Joo Chng

rp04705

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Wee Joo Chng
Variants
Chng W.J
Chng, W.J.
Chng W.-J.
Wee Joo Chng
Chng, W.-J.
 
Main Affiliation
 
Faculty
 
Email
mdccwj@nus.edu.sg
 
Other emails
 

Publications

Refined By:
Department:  OFFICE OF THE DEPUTY PRESIDENT(RES&TECH)
Subject:  human

Results 1-20 of 21 (Search time: 0.02 seconds).

Issue DateTitleAuthor(s)
12018A loss-of-function genetic screening reveals synergistic targeting of AKT/mTOR and WTN/β-catenin pathways for treatment of AML with high PRL-3 phosphataseZhou, J ; Toh, S.H.-M; Chan, Z.-L; Quah, J.Y; Chooi, J.-Y ; Tan, T.Z ; Chong, P.S.Y ; Zeng, Q ; Chng, W.-J 
222016Aberrant localization of apoptosis protease activating factor-1 in lipid raft sub-domains of diffuse large B cell lymphomasHirpara, J.L ; Loh, T ; Ng, S.B ; Chng, W.J ; Pervaiz, S 
23Jul-2017Belinostat exerts antitumor cytotoxicity through the ubiquitin-proteasome pathway in lung squamous cell carcinomaKong, L.R ; Tan, T.Z ; Ong, W.R; Bi, C; Huynh, H ; Lee, S.C ; Chng, W.J ; Eichhorn, P.J.A ; Goh, B.C 
242018Celastrol attenuates the invasion and migration and augments the anticancer effects of bortezomib in a xenograft mouse model of multiple myelomaShanmugam, M.K ; Ahn, K.S; Lee, J.H; Kannaiyan, R; Mustafa, N ; Manu, K.A ; Siveen, K.S ; Sethi, G ; Chng, W.J ; Kumar, A.P 
252016Exocytosis of polyubiquitinated proteins in bortezomib-resistant leukemia cells: A role for MARCKS in acquired resistance to proteasome inhibitorsFranke, N.E; Kaspers, G.L; Assaraf, Y.G; Meerloo, J; Niewerth, D; Kessler, F.L; Poddighe, P.J; Kole, J; Smeets, S.J; Ylstra, B; Bi, C; Chng, W.J ; Horton, T.M; Menezes, R.X; Musters, R.J.P; Zweegman, S; Jansen, G; Cloos, J
262015Genome-wide pharmacologic unmasking identifies tumor suppressive microRNAs in multiple myelomaBi, C; Chung, T.-H ; Huang, G ; Zhou, J ; Yan, J ; Ahmann, G.J; Fonseca, R; Chng, W.J 
272017Inhibition of LIN28B impairs leukemia cell growth and metabolism in acute myeloid leukemiaZhou, J ; Bi, C; Ching, Y.Q ; Chooi, J.-Y ; Lu, X; Quah, J.Y ; Toh, S.H.-M ; Chan, Z.-L; Tan, T.Z ; Chong, P.S ; Chng, W.-J 
282018Low-level expression of SAMHD1 in acute myeloid leukemia (AML) blasts correlates with improved outcome upon consolidation chemotherapy with high-dose cytarabine-based regimensRassidakis, G.Z; Herold, N; Myrberg, I.H; Tsesmetzis, N; Rudd, S.G; Henter, J.-I; Schaller, T; Ng, S.-B ; Chng, W.J ; Yan, B; Ng, C.H ; Ravandi, F; Andreeff, M; Kantarjian, H.M; Medeiros, L.J; Xagoraris, I; Khoury, J.D
292015Pharmacokinetics and safety of ixazomib plus lenalidomide-dexamethasone in Asian patients with relapsed/refractory myeloma: a phase 1 studyGupta, N; Goh, Y.T ; Min, C.-K; Lee, J.H; Kim, K; Wong, R.S.M; Chim, C.S; Hanley, M.J; Yang, H; Venkatakrishnan, K; Hui, A.-M; Esseltine, D.-L; Chng, W.J 
302018Potential clinical application of genomics in multiple myelomaSoekojo, C.Y; de Mel, S; Ooi, M ; Yan, B; Chng, W.J 
312018Preleukemic and second-hit mutational events in an acute myeloid leukemia patient with a novel germline RUNX1 mutationNg, I.K.S; Lee, J; Ng, C; Kosmo, B; Chiu, L; Seah, E; Mok, M.M.H ; Tan, K; Osato, M ; Chng, W.-J ; Yan, B; Tan, L.K 
322016PRIMA-1 targets the vulnerability of multiple myeloma of deregulated protein homeostasis through the perturbation of ER stress via p73 demethylationTeoh P.J. ; Bi C.; Sintosebastian C.; Tay L.S. ; Fonseca R.; Chng W.J. 
332015PRIMA-1met (APR-246) inhibits growth of colorectal cancer cells with different p53 status through distinct mechanismsLi, X.-L; Zhou, J ; Chan, Z.-L; Chooi, J.-Y ; Chen, Z.-R; Chng, W.-J 
342014Prognostic implication of morphology, cyclinE2 and proliferation in EBV-associated T/NK lymphoproliferative disease in non-immunocompromised hostsNg, S.-B ; Ohshima, K; Selvarajan, V ; Huang, G; Choo, S.-N; Miyoshi, H; Wang, S ; Chua, H.-C ; Yeoh, A.E.-J ; Quah, T.-C ; Koh, L.-P ; Tan, P.-L ; Chng, W.-J 
352017Recent advances in acute promyelocytic leukaemiaNg, C.-H ; Chng, W.-J 
362016The emerging roles of exosomes in leukemogeneisZhou, J ; Wang, S; Sun, K; Chng, W.-J 
172018The role of signal transducer and activator of transcription 3 (STAT3) and its targeted inhibition in hematological malignanciesArora, L; Kumar, A.P ; Arfuso, F; Chng, W.J ; Sethi, G 
182016Thrombotic microangiopathy during carfilzomib use: case series in SingaporeChen, Y; Ooi, M. ; Lim, S.F; Lin, A; Lee, J; Nagarajan, C; Phipps, C; Lee, Y.S; Grigoropoulos, N.F ; Lao, Z ; Surendran, S; Teh, E.M; Goh, Y.T ; Chng, W.J ; Gopalakrishnan, S.K 
192014Thymoquinone overcomes chemoresistance and enhances the anticancer effects of bortezomib through abrogation of NF-?B regulated gene products in multiple myeloma xenograft mouse modelSiveen, K.S ; Mustafa, N ; Li, F ; Kannaiyan, R; Ahn, K.S; Kumar, A.P ; Chng, W.-J ; Sethi, G 
202017Tumor-derived exosomes in colorectal cancer progression and their clinical applicationsZhou, J ; Li, X.-L; Chen, Z.-R; Chng, W.-J